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Abstract
It is often assumed that neuropsychological measures are ecologically valid in ‘normal’ people, but this assumption has not yet
been thoroughly evaluated.
The aim of the present study was to evaluate the cross-sectional and longitudinal ecological validity of individual neuropsy-
chological test scores and their composites in a large sample of neurologically intact people. Three neuropsychological composite
measures were established, i.e. a “Memory Quotient”, an “Executive functioning and Speed Quotient”, and a “General Cogni-
tive Quotient”. The ecological validity of the individual neuropsychological measures and their composites was low to moderate.
Multivariate models that included both neuropsychological and non-cognitive variables (i.e. demographic variables, depressive
symptoms and anxiety) accounted for 4.6–21.4% of the variance in daily life functioning. The General Cognitive Quotient was the
neuropsychological measure that was the most consistently related to daily life functioning.
© 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.
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1. Introduction
Historically, neuropsychological tests have mainly been used to detect and localize brain pathology (Long & Kibby,
1995). As brain imaging techniques became more widely available in recent decades, the role of neuropsychological
assessment in the diagnosis of neuropathology has gradually diminished (Johnstone & Frank, 1995; Rabin, Burton,
& Barr, 2007). Today, referral questions in clinical neuropsychology are increasingly more focused on the functional
implications of brain damage, such as whether or not a patient is able to follow a rehabilitation program, live inde-
pendently, or return to work (Rabin, Barr, & Burton, 2005). The degree to which neuropsychological tests can make
accurate predictions of a person’s behavior in real-world settings has been defined as the ecological validity of a test
(Sbordone, 1996).
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Various studies have evaluated the ecological validity of neuropsychological tests. For example, Chaytor, Schmitter-
Edgecombe, and Burr (2006) evaluated the relationship between tests that measure executive functioning (such as the
Trail Making Test) and everyday executive ability (as measured with informant ratings) in a sample of 46 mixed
neurological adult patients. The authors found that the neuropsychological test scores accounted for about 20% of
the variance in the measures of everyday executive ability. Farias, Harrell, Neumann, and Houtz (2003) evaluated
the ecological validity of composite neuropsychological test scores in a sample of 42 people with Alzheimer’s dis-
ease. The results showed that these neuropsychological composites accounted for about 20–50% of the variance in
performance-based measures of daily living skills (e.g. dialing a telephone, counting currency), and for about 10–30%
of the variance in informant-based functional ratings. These and similar studies suggested that the ecological validity
of neuropsychological test scores is moderate, at least in clinical populations (for comprehensive reviews refer to
Chaytor and Schmitter-Edgecombe (2003), Green, Kern, and Heaton (2004), and Kalechstein, Newton, and Van Gorp
(2003)).
Until now, the ecological validity of neuropsychological instruments has not been carefully considered in ‘neu-
rologically intact’ people (Spooner & Pachana, 2006). This is not surprising, as neuropsychology has traditionally
been a discipline with a strong focus on neurologically impaired people. The ecological validity of neuropsychological
tests in neurologically intact individuals, however, is an important issue that may have implications for studies in
neuropsychology and related fields. For example, studies that evaluate the impact of pharmacological manipulations
(such as tryptophan depletion; Evers, Van der Veen, Jolles, Deutz, & Schmitt, 2006), illegal drugs (such as marijuana;
Ramaekers et al., 2006), medical variables (such as hypertension; Van Boxtel et al., 2006), or nutritional components
(such as fatty acids; De Groot, Hornstra, & Jolles, 2007) on the cognitive abilities of neurologically intact people would
be of limited value if the neuropsychological test scores were not related to real-world functioning.
The aim of the present study was to evaluate the cross-sectional and the longitudinal ecological validity of
neuropsychological measures in neurologically intact mid-aged to older adults (aged between 49 and 81 years at
baseline). Neuropsychological measures (assessed at baseline) were related to daily life functioning as assessed
at baseline (i.e. cross-sectional ecological validity) and at several follow-up moments (i.e. longitudinal ecological
validity). Both individual neuropsychological test scores and their composites were related to daily life function-
ing because previous studies have suggested that composite scores had higher ecological validity as compared to
individual neuropsychological test scores (see the reviews of Chaytor & Schmitter-Edgecombe, 2003; Green et
al., 2004; Kalechstein et al., 2003). As previous studies have suggested that demographical variables (Kalechstein
et al., 2003), depressive symptoms (Chaytor, Temkin, Machamer, & Dikmen, 2007), and anxiety (Sbordone,
1996) may account for substantial parts of the variance in daily life measures (in addition to neuropsychologi-
cal functioning), we also evaluated the contribution of these non-cognitive variables in the prediction of daily life
functioning.
2. Method
2.1. Participants
Data were derived from the Maastricht Aging Study (MAAS), a prospective study on the determinants of cog-
nitive aging. MAAS baseline measurements were conducted between 1993 and 1996 and involved four panels of
approximately 465 people each (1856 individuals in total). The data were collected in four smaller panels instead
of in a single large panel for logistic reasons. All participants were community dwelling, healthy people (aged
between 24 and 81 years at baseline) who were without documented medical conditions that could interfere with
normal cognitive functioning (i.e. individuals with chronic neurological pathology, mental retardation, psychopathol-
ogy, or chronic psychotropic drug use were excluded). For the present study, we only included people who were
aged 49 years or older at baseline because the follow-up frequency in the MAAS differed as a function of baseline
age.
At baseline, all participants were administered the Stroop Color-Word Test (SCWT; Stroop, 1935), Concept Shifting
Test (CST; Van der Elst, Van Boxtel, Van Breukelen, & Jolles, 2006a), Letter Digit Substitution Test (LDST; Van der
Elst, Van Boxtel, Van Breukelen, & Jolles, 2006b), Verbal Learning Test of Rey (VLT; Van der Elst, Van Boxtel,
Van Breukelen, & Jolles, 2005), Mini-Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 1975), and
the depression and anxiety scales of the Symptom Checklist 90 (SCL-90; Derogatis, 1977). Data of people with
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Table 1
Descriptive data (N, mean (M), standard deviation (S.D.), and score range) for the neuropsychological measures, depressive symptoms and anxiety,
and the outcome measures at the different measurement moments
Measurement moment Variable N M S.D. Score range
Baseline SCWT Time 859 103.85 25.55 53.6–223.8
SCWT Errors 859 1.51 2.39 0–22
CST Shifting 859 14.62 12.63 −9.8 to 121.40
CST Errors 859 .67 1.13 0–8
VLT Total recall 1–3 859 21.76 5.38 9–39
VLT Delayed recall 859 9.07 2.86 1–15
LDST 60 s 859 29.06 6.76 10–50
Depressive symptoms 859 20.96 6.31 16–62
Anxiety 832 12.72 4.24 10–47
SF-36 PF 442 25.76 3.91 12–30
CFQ 579 31.84 10.90 2–73
DECO Not administered
First follow-up SF-36 PF 614 25.43 4.25 10–30
CFQ 585 30.79 11.42 2–76
DECO 612 34.99 4.25 5–38
Second follow-up SF-36 PF 608 24.88 4.62 10–30
CFQ Not administered
DECO 559 35.11 3.61 17–38
Third follow-up SF-36 PF 552 24.59 4.78 10–30
CFQ Not administered
DECO 600 34.70 4.25 10–38
Note. SCWT, Stroop Color-Word Test; CST, Concept Shifting Test; VLT, Verbal Learning Test; LDST, Letter Digit Substitution Test; SF-36 PF,
Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey; CFQ, Cognitive Failures Questionnaire; DECO,
Détérioration Cognitif Observée (observed deterioration of cognitive functioning).
missing values in the cognitive measures or with MMSE scores below 24 (a commonly employed cut-off to screen
for dementia) were excluded from the analyses. The baseline data of n= 859 people were eligible for use in the
analyses.
Daily life functioning was measured with self-report and informant questionnaires. The Medical Outcomes Study
36-Item Short Form Health Survey (SF-36; Van der Zee & Sanderman, 1993; Ware & Sherbourne, 1992) was given
to two of the four panels of MAAS at baseline (n= 442) and to all four panels at the first, second, and third follow-up
occasions (n= 614, n= 608 and n= 552, respectively). The test–retest interval between each of the four consecutive
measurement moments was 3 years. The Détérioration Cognitif Observée (in English: observed deterioration of
cognitive functioning) (DECO; Ritchie & Fuhrer, 1996) was given to all four panels at the first (n= 612), second
(n= 559), and third (n= 600) follow-up moments, but was not administered to any of the panels at baseline. The
Cognitive Failures Questionnaire (CFQ; Broadbent, Cooper, FitzGerald, & Parkes, 1982) was administered to three
panels at baseline (n= 579) and to four panels at the first follow-up moment (n= 585).
The ethnic background of all participants was Caucasian, and all participants were native Dutch speakers. At
baseline, 38.4% of the sample was aged between 49 and 59 years, 35.2% was aged between 60 and 69 years, and
26.4% was aged 70+ years. Level of education (LE) was measured by classifying the formal schooling of participants
in one of three groups, namely those with at most primary education (LE low; 46.9% of the total sample at baseline),
those with at most junior vocational training or high school (LE average; 36.0% of the sample), and those with at
most senior vocational or academic training (LE high; 17.1% of the sample). The proportion of males and females
was approximately equal (with 48.9% males). The mean (S.D.) IQ of the participants was 115.6 (13.2) at baseline (IQ
was measured with the shortened version of the Groningen Intelligence Test; Luteijn & Van der Ploeg, 1983). Table 1
provides descriptive data of the neuropsychological test scores, the depression and anxiety measures, and the daily life
measures per measurement moment. The medical ethics committee of Maastricht University approved the study and
all participants gave their informed consent.
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2.2. Measures
2.2.1. Neuropsychological tests
The SCWT, CST, VLT and LDST were administered individually at the neuropsychological laboratory of the School
for Mental Health and Neuroscience, University Maastricht (the Netherlands) by highly trained test assistants.
The SCWT is a measure of executive and related functions (Hammes, 1973; Van der Elst, Van Boxtel, Van Breukelen,
& Jolles, 2006c). The three SCWT subtasks display names of colors (red, blue, yellow, green) in random order printed
in black ink, solid color patches in one of these four basic colors, and color words printed in an incongruous ink color,
respectively. The participants were instructed to read the words, name the colors, and name the ink color of the printed
words as quickly and as accurately as possible. The time needed to complete the SCWT subtask three (measured in
seconds) and the number of errors that were made in subtask three served as the outcome variables (SCWT Time and
SCWT Errors, respectively).
The CST is a Trail Making Type test that measures concept shifting and related cognitive functions (Van der Elst
et al., 2006a). In each of five parts, a sheet of paper is presented that contains 16 small circles arranged in a larger
circle. The small circles contain digits (part A), letters (part B), both digits and letters (part C), or are empty (parts
D and E). Participants were instructed to cross out, as quickly and as accurately as possible, the fixed randomly
arranged numbers 1–16 in numerical order (part A), the fixed randomly arranged letters A–P in alphabetical order
(part B), the fixed randomly arranged numbers alternating with letters in the appropriate order (1, A, 2, B etc.; part
C), and the 16 empty circles in a clockwise fashion (parts D and E). The time needed to complete parts A, B and C
of the CST is referred to as CSTa, CSTb, and CSTc, respectively. Outcomes measures were the Shifting score (CST
shifting = CSTc − [CSTa + CSTb]/2) and the number of errors made in CST part C (CST Errors).
The VLT is a word learning test that measures diverse components of verbal memory (Schmidt, 1996; Van der
Elst et al., 2005). Fifteen words were presented in a fixed order with an inter-stimulus interval of 1 s. As soon as the
presentation stopped, the participants were asked to repeat as many words as possible in any order. This procedure
was repeated four more times, after which there was a delay of about 20 min. Next, participants were again instructed
to recall the words learned. Finally, a recognition trial was administered. Outcome variables were the total number of
correctly recalled words summed over the first three trials (VLT Total recall 1–3), and the number of correctly recalled
words after the 20-min delay (VLT Delayed recall).
The LDST is a substitution type test that measures general speed of information processing (Van der Elst et al.,
2006b). In the LDST, participants were required to replace randomized letters with appropriate digits as quickly and
accurately as possible. The number of correct substitutions made in 60 s served as the outcome variable (LDST 60 s).
2.2.2. Outcome measures
The participants were given the SF-36 and the CFQ self-report questionnaires. The SF-36 assesses various health
dimensions. Among these dimensions is the SF-36 physical functioning (SF-36 PF) scale, a scale that is highly
correlated with ADL measures (e.g. Martin, Irrgang, Burdett, Conti, & Van Swearingen, 2005; Reijneveld, Spijker,
& Dijkshoorn, 2007) and which is sensitive for mild functional losses that affect independent living in older people
(Anderson, Laubscher, & Burns, 1996). The SF-36 PF scale is composed of 10 items about mobility (e.g. lifting
or carrying groceries) and self-care (e.g. bathing or dressing oneself) that are rated on a 3-point Likert scale (score
range between 1 and 3). The SF-36 PF scale score range is between 10 and 30, with lower scale scores reflecting
less functional independence and lower ADL capacities. The CFQ is an IADL questionnaire that consists of 29 items
regarding the frequency of the occurrence of cognitive lapses in daily life (e.g. forgetting appointments). Each item is
rated on a 5-point Likert scale (score range between 0 and 4). The CFQ total test score ranges between 0 and 116, with
higher scores reflecting a higher frequency of cognitive failures in daily life.
In addition to the self-report questionnaires, the DECO was filled in by an informant. The DECO assesses changes
that have occurred over the past year in a person’s IADL functioning (Ritchie, Artero, & Touchon, 2001). The DECO
consists of 19 items about changes that occurred in various activities of daily life (e.g. managing money). Items are
rated on a 3-point Likert scale with a score range between 0 and 2. The total DECO score ranges between 0 and 38,
with lower scores reflecting larger changes in a person’s IADL.
Depressive symptoms and anxiety were measured with the depression and anxiety scales of the SCL-90 self-report
questionnaire. The SCL-90 items are rated on a 5-point Likert scale with a score range between 1 and 5. The depression
scale is composed of 16 items about depression (e.g. feeling lonely). The anxiety scale consists of 10 items about anxiety
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(e.g. feeling afraid). The total depression and anxiety scale scores range between 16 and 80 and between 10 and 100,
respectively (with higher scale scores reflecting more depressive symptoms and higher anxiety levels, respectively).
2.3. Statistical analyses
The seven neuropsychological test scores were subjected to Principal Components Analyses (PCAs). The first PCA
was exploratory, using the eigenvalue >1.0 criterion (Guttman, 1954) and the scree plot (Cattell, 1966) to determine
the number of components to be retained. The second PCA forced the extraction of one component, because different
theories have suggested that all cognitive tests measure a general factor common to all cognitive tests (factor g in the
intelligence and cognition literature; Spearman, 1927), as well as test-specific factors.
Next, the individual neuropsychological test scores, the composites, and the non-cognitive variables (demographics,
depressive symptoms and anxiety) were correlated with the daily life measures. Such bivariate correlations are infor-
mative, but neuropsychologists usually base their judgment of an individual’s everyday functioning on a combination
of non-cognitive variables and multiple neuropsychological measures – rather than on a single neuropsychological
measure. Linear mixed models (LMM) analyses were conducted to evaluate the contribution of the various predictors
on daily life functioning. There were three LMM analyses for each daily life outcome measure: one with the seven
individual neuropsychological test scores as predictors, another with the neuropsychological composites resulting from
the exploratory PCA as predictors, and a third with the neuropsychological composite resulting from the 1-component
PCA as a predictor. In addition to the neuropsychological test measures, demographic variables (age, age2, gender,
level of education), depressive symptoms, anxiety, time and all two-way interactions between these predictors and the
three-way interactions involving time were included as predictors in the full models. Time was coded with three dum-
mies (first follow-up, second follow-up and third follow-up) and baseline measurement as the reference category. Age
was centred (age = calendar age − 65) before computing the quadratic terms and interactions to avoid multicollinearity
(Marquardt, 1980). Gender was dummy coded with male = 1 and female = 0. LE was dummy coded with two dummies
(LE low and LE high) and LE average as the reference category.
The full models were reduced in a stepwise hierarchical manner by eliminating the least significant predictor if its
two-tailed p-value was above .01. No predictor was removed from the model as long as it was also included in a higher-
order term in the model. All models were estimated with restricted maximum likelihood, rather than with maximum
likelihood, because restricted maximum likelihood is better for estimating the covariance matrix and the standard errors
of fixed effects. The mixed model assumed fixed effects of all predictors and an unstructured covariance matrix for the
repeated measures. This is equivalent to the multivariate method for ANOVA of repeated measures for complete data,
but unlike repeated measures ANOVA, LMM can handle missing data without requiring either imputation of missing
values or list-wise deletion of persons with a missing value (Verbeke & Molenberghs, 2000). In the present study,
15.6%, 22.9% and 29.2% of the people who were tested at baseline dropped-out from the study at the first, second,
and third follow-up moments, respectively. Previous studies with the MAAS data have shown that especially older and
lower educated people tend to drop-out (Van Beijsterveldt et al., 2002; Van der Elst, Van Boxtel, Van Breukelen, &
Jolles, 2008), but this is not a problem when LMM is used because this method is valid even if the drop-out pattern
depends on the observed covariates or previous repeated measures (in contrast to repeated measures ANOVA) (Verbeke
& Molenberghs, 2000). Assumptions of linearity, normality of the residuals (normal distribution of the residuals for
the various measurement moments), and homoscedasticity (homogenous variance of the residuals over the range of
the predicted scores at the different measurement occasions) were examined graphically and analytically for each final
model. For technical details of LMM with time and between-subject variables, see Verbeke and Molenberghs (2000)
and Van Breukelen (2006).
All analyses were conducted using SPSS 14.0 for Windows, with alpha = .01 for all analyses. A lower alpha level
was chosen in order to avoid Type I errors due to multiple testing.
3. Results
3.1. Neuropsychological composites
Unlike the VLT and the LDST test scores, higher SCWT and CST test scores reflect worse performance. For this
reason, the signs of the SCWT Time, SCWT Errors, CST Shifting and CST Errors scores were reversed (i.e. their
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Table 2
Component loadings that were obtained by Principal Components Analyses in which two (left column) and one (right column) components were
extracted
Test score (at baseline) 2-component solution 1-component solution
Component I Component II Component I
SCWT Time .27 .61 .74
SCWT Errors −.11 .60 .42
CST Shifting −.12 .75 .54
CST Errors −.13 .61 .41
VLT Total recall 1–3 .94 −.07 .72
VLT Delayed recall .95 −.11 .70
LDST 60 s .30 .58 .75
Initial eigenvalues for each component 2.75 1.22 2.75
Percentage of variance accounted for 39.31% 17.40% 39.31%
Note. SCWT, Stroop Color-Word Test; CST, Concept Shifting Test; VLT, Verbal Learning Test; LDST, Letter Digit Substitution Test. The signs of
the SCWT Time, SCWT Errors, CST Shifting and CST Errors scores were reversed. The 2-component solution that is presented in this table (left
column) is promax-rotated. The correlation between the promax-rotated components of the 2-component solution equaled .37 (p< .001). Eigenvalues
and percentage of variance explained refer to the unrotated components. Component loadings ≥ 40 are printed in boldface.
original values were multiplied by −1). The reversed SCWT Time, SCWT Errors, CST Shifting and CST Errors
scores, and the raw LDST 60 s, VLT Total recall 1–3, and the VLT Delayed recall scores were subjected to PCAs.
The eigenvalue >1.0 criterion suggested a 2-component solution, which was confirmed by inspection of the scree plot.
These two components accounted for 56.7% of the total variance. The promax-rotated solution is presented in Table 2
(left column). Component I was defined by the VLT Total recall 1–3 and VLT Delayed recall scores, and can be labeled
as the (verbal) “memory component”. Component II was defined by the SCWT Time, SCWT Errors, CST Shifting,
CST Errors and LDST 60 s scores, and can be termed the “executive functioning and speed component”. A second
PCA was conducted on the individual neuropsychological test scores in which only one component was extracted
(see Table 2, right column). This “general cognition component” accounted for 39.3% of the total variance, and all
individual neuropsychological test scores had loadings above .40 on this component.
The results of the PCAs were used to establish the neuropsychological composites. This required four steps. First,
the test scores that had loadings of at least .40 on the component to-be-computed were converted into z-scores (z-
scorei = [raw test score − mean raw score in MAAS]/[S.D.(raw score)]) by means of Table 1 (note that the signs of
the raw and the mean SCWT and CST scores have to be reversed). Second, these z-scores were multiplied with the
component coefficients (ci’s) and aggregated (aggregated scorei = [z-scorei × ci]). Third, the aggregated scores were
divided by the S.D.s of the aggregated scores in the total MAAS sample to obtain component scores (component
scorei = aggregated scorei/S.D.[aggregated scores in MAAS]). The S.D. (aggregated scores in MAAS) values equaled
1.77, 2.10 and 2.64 in the computation of the memory, executive functioning and speed, and general cognition com-
ponents, respectively. Fourth, the component scores were linearly transformed and placed on a scale with a mean
of 100 and an S.D. of 15 (i.e. an IQ scale). The transformed scores will be referred to as the Memory Quotient
(MQ = [Memory Component scorei × 15] + 100), Executive functioning and Speed Quotient (ESQ = [Executive func-
tioning and Speed Component scorei × 15] + 100) and the General Cognitive Quotient (GCQ = [General Cognitive
Component scorei × 15] + 100) measures, respectively. These transformations were conducted to increase the ease of
interpretation of the neuropsychological composites.
3.2. Correlation analysis
The results of a series of correlational analyses are presented in Table 3. The SCWT Time and LDST 60 s scores
were significantly correlated with all outcome measures (with the exception of the baseline CFQ score for the SCWT
Time measure, and the baseline CFQ and second follow-up DECO scores for the LDST 60 s score, respectively). The
VLT Total recall 1–3 and VLT Delayed recall measures were significantly correlated with the SF-36 PF scores at the
second and third follow-up moments, and with the DECO scores at each measurement moment. The CST Shifting
score was significantly correlated with the SF-36 PF scores at the first, second, and third follow-up moments. The CST
W
.V
a
n
derElst
et
al./A
rchives
ofClinicalNeuropsychology
23(2008)787–800
793
Table 3
Correlations between the individual neuropsychological test scores, their composites, demographic variables, depressive symptoms, anxiety, and the measures of daily life functioning
SF-36 PF
baseline
SF-36 PF first
follow-up
SF-36 PF second
follow-up
SF-36 PF third
follow-up
DECO first
follow-up
DECO second
follow-up
DECO third
follow-up
CFQ baseline CFQ first
follow-up
SCWT Time −.221 −.193 −.225 −.277 −.164 −.179 −.174 .041 .107
SCWT Errors −.028 −.111 −.064 −.060 −.093 −.116 −.070 .065 .046
CST Shifting −.109 −.165 −.135 −.188 −.062 −.005 −.055 .037 .079
CST Errors −.155 −.108 −.102 −.142 −.066 −.099 −.162 .073 .039
VLT Total recall 1–3 .101 .067 .154 .183 .191 .166 .189 −.014 −.067
VLT Delayed recall .075 .065 .151 .157 .253 .184 .137 −.001 −.046
LDST 60 s .220 .216 .206 .234 .146 .102 .131 −.082 −.127
ESQ .232 .248 .236 .285 .161 .152 .181 −.095 −.132
MQ .094 .072 .166 .184 .241 .192 .176 −.007 −.060
GCQ .218 .211 .265 .314 .248 .219 .229 −.063 −.126
Depressive symptoms −.192 −.178 −.156 −.166 −.170 −.145 −.123 .333 .301
Anxiety −.169 −.150 −.172 −.185 −.149 −.111 −.131 .322 .266
Age −.288 −.314 −.380 −.419 −.205 −.244 −.216 −.047 −.001
Gender .093 .159 .097 .112 −.074 −.103 −.099 −.087 −.167
LE low −.199 −.165 −.202 −.249 −.136 −.085 −.170 .093 .126
LE high .048 .070 .102 .145 .031 .094 .139 −.016 −.065
Note. SF-36 PF, Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey; DECO, Détérioration Cognitif Observée (observed deterioration of cognitive
functioning); CFQ, Cognitive Failures Questionnaire; SCWT, Stroop Color-Word Test; CST, Concept Shifting Test; VLT, Verbal Learning Test; LDST, Letter Digit Substitution Test; ESQ,
Executive functioning and Speed Quotient; MQ, Memory Quotient; GCQ, General Cognitive Quotient; LE, level of education. Coding of the predictors: Gender: 1 if male, 0 if female; LE low:
Low Education = 1, Average or High Education = 0; LE high: High Education = 1, Low or Average Education = 0. Correlations in boldface are significant (p< .01).
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Errors score was significantly correlated with the baseline, first-follow-up, and third follow-up SF-36 PF scores, and
with the DECO score at the third follow-up. The SCWT Errors score was only significantly correlated with the SF-36
PF first follow-up score. The ESQ and GCQ scores were significantly correlated with all outcome measures (with the
exception of the CFQ score at baseline). The MQ measure was significantly correlated with the SF-36 PF scores at the
second and third follow-up moments, and with the DECO scores at all measurement moments.
Age was significantly correlated with the SF-36 PF and DECO scores at all measurement moments. LE was
significantly correlated to most, but not all, measures of daily life functioning (especially LE low, see Table 3).
Correlations between gender and the daily life measures were low and mostly non-significant. Depressive symptoms
and anxiety were significantly related to all daily life outcome measures at each measurement moment.
3.3. The prediction of daily life functioning based on neuropsychological measures and non-cognitive variables
For each outcome variable, three full models were constructed. Each full model included the neuropsychological
measures (i.e. the seven individual neuropsychological test scores, the ESQ and MQ measures, or the GCQ measure),
Table 4
Coefficients, standard errors, T-values and their significance levels for the final mixed models that included the individual neuropsychological test
scores, time, age, age2, gender, level of education, depressive symptoms, anxiety, and the relevant interactions as predictors in the full models, and
the SF-36 PF, CFQ and DECO scores as outcome variables
Outcome Variable Estimate S.E. T
SF-36 PF (Constant) 29.002 .528 54.928**
Age −.134 .020 −6.713**
Age2 −.005 .002 −2.850**
LE low −.928 .294 −3.154**
LE high .260 .375 .692
Depressive symptoms −.135 .023 −5.915**
First follow-up −.352 .199 −1.765
Second follow-up −1.336 .209 −6.376**
Third follow-up −2.069 .233 −8.875**
Age × first follow-up −.042 .018 −2.290
Age × second follow-up −.112 .019 −5.839**
Age × third follow-up −.151 .021 −7.070**
SCWT Error .150 .077 1.939
SCWT Errors × first follow-up −.255 .082 −3.124**
SCWT Errors × second follow-up −.196 .085 −2.310
SCWT Errors × third follow-up −.160 .094 −1.705
CFQ (Constant) 19.003 2.086 9.109**
Depressive symptoms .343 .099 3.462**
Anxiety .452 .156 2.895**
First follow-up −5.636 1.609 −3.504**
SCWT Time −.0001 .016 −.006
SCWT Time × first follow-up .048 .016 3.042**
DECO (Constant) 35.883 .735 48.830**
Age −.103 .015 −6.702**
Gender −.885 .258 −3.426**
Depressive symptoms −.118 .021 −5.499**
Second follow-up −.078 .169 −.461
Third follow-up −.621 .181 −3.433**
VLT Delayed Recall .193 .049 3.970**
Note. Estimate, B regression weight; SF-36 PF, Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey;
CFQ, Cognitive Failures Questionnaire; DECO, Détérioration Cognitif Observée (observed deterioration of cognitive functioning); SCWT, Stroop
Color-Word Test; VLT, Verbal Learning Test. Coding of the predictors: Age = calendar age − 65; Age2 = (calendar age − 65)2; Gender: 1 if male, 0
if female; LE low: Low Education = 1, Average or High Education = 0; LE high: High Education = 1, Low or Average Education = 0; First follow-up:
1 if first follow-up moment, 0 if other measurement moment; Second follow-up: 1 if second follow-up moment, 0 if other measurement moment;
Third follow-up: 1 if third follow-up moment, 0 if other follow-up moment.
** p< .005.
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time, age, age2, gender, level of education, depressive symptoms and anxiety (and all two-way interactions between
these predictors and the three-way interactions involving time). The final models that resulted from the hierarchical
stepwise procedure are referred to as the ‘final individual test score models’, the ‘final ESQ and MQ models’ and
the ‘final GCQ models’. These models are presented in Tables 4–6. Model assumptions of linearity, normality of the
residuals, and homoscedasticity were met for all models with the exception of the small tendencies to heteroscedasticity
for the models that predicted the SF-36 PF and DECO scores (i.e. the variance of the residuals decreased as a function
of increasing predicted scores at all measurement moments).
The final individual test score model of the SF-36 PF score showed that lower levels of education and more
depressive symptoms affected the SF-36 PF scores negatively at all measurement moments. The decline in SF-36 PF
scores over time was stronger for older people and for people who obtained higher SCWT Error scores (at baseline).
People with more depressive symptoms and higher anxiety scores (at baseline) were predicted to have higher CFQ
scores at the various measurement moments. The increase in CFQ scores over time was more pronounced for people
with higher SCWT Time scores (at baseline) (note that higher CFQ and higher SCWT Time scores reflect worse
functioning). Higher age, being female, more depressive symptoms and lower VLT Delayed recall scores (at baseline)
were associated with lower DECO scores at all measurement moments.
The final ESQ and MQ models showed that the decline over time in SF-36 PF scores was more pronounced for older
people. More depressive symptoms and lower ESQ scores (at baseline) were negatively associated with the SF-36 PF
scores at all measurement moments. The MQ score did not affect the SF-36 PF score at any measurement moment.
More depressive symptoms and higher anxiety scores (at baseline) were associated with higher CFQ scores at all
Table 5
Coefficients, standard errors, T-values and their significance levels for the final mixed models that included the ESQ, MQ, time, age, age2, gender,
level of education, depressive symptoms, anxiety, and the relevant interactions as predictors in the full models, and the SF-36 PF, CFQ and DECO
scores as outcome variables
Outcome Variable Estimate S.E. T
SF-36 PF (Constant) 24.980 1.186 21.063**
Age −.095 .019 −4.912**
Depressive symptoms −.133 .023 −5.885**
First follow-up −.711 .164 −4.328**
Second follow-up −1.611 .173 −9.309**
Third follow-up −2.304 .193 −11.929**
Age × first follow-up −.047 .018 −2.560*
Age × second follow-up −.115 .019 −5.979**
Age × third follow-up −.154 .021 −7.199**
ESQ .035 .010 3.391**
CFQ (Constant) 21.983 3.359 6.544**
Depressive symptoms .336 .099 3.400**
Anxiety .449 .156 2.880**
First follow-up 6.835 2.932 2.331
ESQ −.028 .029 −.969
ESQ × first follow-up −.075 .028 −2.646**
DECO (Constant) 33.669 1.155 29.150**
Age −.100 .016 −6.456**
Gender −.865 .258 −3.349**
Depressive symptoms −.120 .021 −5.607**
Second follow-up −.083 .169 −.494
Third follow-up −.619 .181 −3.423**
MQ .040 .010 4.160**
Note. Estimate, B regression weight; SF-36 PF, Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey;
CFQ, Cognitive Failures Questionnaire; DECO, Détérioration Cognitif Observée (observed deterioration of cognitive functioning); MQ, Memory
Quotient; ESQ, Executive functioning and Speed Quotient. Coding of the predictors: Age = calendar age − 65; Gender: 1 if male, 0 if female; First
follow-up: 1 if first follow-up moment, 0 if other measurement moment; Second follow-up: 1 if second follow-up moment, 0 if other measurement
moment; Third follow-up: 1 if third follow-up moment, 0 if other follow-up moment.
* p< .01.
** p< .005.
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Table 6
Coefficients, standard errors, T-values and their significance levels for the final mixed models that included the GCQ, time, age, age2, gender, level
of education, depressive symptoms, anxiety, and the relevant interactions as predictors in the full models, and the SF-36 PF, CFQ and DECO scores
as outcome variables
Outcome Variable Estimate S.E. T
SF-36 PF (Constant) 25.808 1.199 21.532**
Age −.096 .020 −4.799**
Depressive symptoms −.136 .023 −5.966**
First follow-up −.703 .164 −4.286**
Second follow-up −1.604 .173 −9.272**
Third follow-up −2.300 .193 −11.913**
Age × first follow-up −.047 .018 −2.551*
Age × second follow-up −.115 .019 −5.982**
Age × third follow-up −.155 .021 −7.214**
GCQ .027 .010 2.593*
CFQ (Constant) 19.751 3.273 6.035**
Depressive symptoms .343 .099 3.468**
Anxiety .445 .156 2.850**
First follow-up 7.211 2.733 2.638**
GCQ −.007 .028 −.240
GCQ × first follow-up −.079 .026 −2.987**
DECO (Constant) 33.425 1.183 28.249**
Age −.091 .016 −5.565**
Gender −1.043 .252 −4.139**
Depressive symptoms −.116 .021 −5.420**
Second follow-up −.083 .169 −.492
Third follow-up −.616 .181 −3.406**
GCQ .043 .010 4.263**
Note. Estimate, B regression weight; SF-36 PF, Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey;
CFQ, Cognitive Failures Questionnaire; DECO, Détérioration Cognitif Observée (observed deterioration of cognitive functioning); GCQ, General
Cognitive Quotient. Coding of the predictors: Age = calendar age − 65; Gender: 1 if male, 0 if female; First follow-up: 1 if first follow-up moment,
0 if other measurement moment; Second follow-up: 1 if second follow-up moment, 0 if other measurement moment; Third follow-up: 1 if third
follow-up moment, 0 if other follow-up moment.
* p< .01.
** p< .005.
measurement moments (note that higher CFQ scores reflects worse functioning). The increase in CFQ scores over time
was especially pronounced for people with lower ESQ scores (at baseline). The MQ score did not affect CFQ scores
at any of the measurement moments. Higher age, being female, more depressive symptoms and lower MQ scores (at
baseline) were associated with lower DECO scores at all measurement moments.
The final GCQ models showed that the decline over time in SF-36 PF scores was more pronounced for older people.
More depressive symptoms and lower GCQ scores (at baseline) were associated with lower SF-36 PF scores at all
measurement moments. More depressive symptoms and higher anxiety scores (at baseline) were associated with higher
CFQ scores at all measurement moments (note that higher CFQ scores reflect worse functioning). Higher GCQ scores
(at baseline) predicted less increase in CFQ scores over time. Higher age, being female, more depressive symptoms,
and lower GCQ scores (at baseline) predicted lower DECO scores at all measurement moments.
As shown in Table 7, the final individual test score models, the final ESQ and MQ models, and the final GCQ models
explained between 4.6% and 21.4% of the variance in the daily life measures.
4. Discussion
The aim of the present study was to evaluate the cross-sectional and the longitudinal ecological validity of neu-
ropsychological test scores and their composites in a large sample of neurologically intact mid-aged to older adults. We
first established neuropsychological composites by means of PCAs. A 2-component solution accounted for 56.7% of
the total variance, and a 1-component solution accounted for 39.3% of the variance. These components were referred
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Table 7
Proportion of explained variance in the SF-36 PF, CFQ and DECO scores by the final neuropsychological test score models, the final ESQ and MQ
models, and the final GCQ models (see Tables 4–6)
Final individual test
score models (%)
Final ESQ and MQ
models (%)
Final GCQ
models (%)
SF-36 PF Baseline 11.6 11.4 11.9
First follow-up 13.5 12.0 12.8
Second follow-up 21.4 19.8 20.0
Third follow-up 19.5 17.1 17.2
CFQ Baseline 14.4 14.2 14.4
First follow-up 6.0 6.1 6.2
DECO First follow-up 10.1 9.6 10.0
Second follow-up 4.7 4.6 4.6
Third follow-up 5.8 7.5 6.6
Note. SF-36 PF, Physical Functioning scale of the Medical Outcomes Study 36-Item Short Form Health Survey; CFQ, Cognitive Failures Question-
naire; DECO, Détérioration Cognitif Observée (observed deterioration of cognitive functioning); GCQ, General Cognitive Quotient; MQ, Memory
Quotient; ESQ, Executive functioning and Speed Quotient.
to as the ESQ and MQ measures, and the GCQ measure, respectively. The neuropsychological composites consist of
linear combinations (=weighted sums) of individual test scores, a method that produces statistically sound summary
measures (Miller & Rohling, 2001). Many studies have used neuropsychological composites that consist of unweighted
rather than weighted sums of standardized test scores (e.g. Van Hooren et al., 2005). Both approaches yield highly
correlated composites when all the component loadings of the individual test scores that comprise the composite of
interest are roughly equal to each other (the latter was the case for the MQ score, see Table 2).
Correlations between the neuropsychological scores and the daily life measures ranged between 0 and .32 (see
Table 3). There is no agreement on how strong the association between neuropsychological scores and measures of
daily life functioning should be in order to consider a neuropsychological measure “ecologically valid”. In general,
Pearson correlations of .10, .30, and .50 are considered to correspond to small, medium, and large effects, respectively
(Cohen & Cohen, 1983). Given these conventional effect sizes, the results suggest that the ecological validity of the
neuropsychological measures was low to moderate (i.e. each neuropsychological measure achieved a correlation of at
least .10 with at least one daily life measure, see Table 3).
Neuropsychologists in real-world situations base their judgment regarding the everyday functioning of an individual
on a combination of neuropsychological measures (individual test scores or composites) and non-cognitive variables.
The contribution of neuropsychological measures and non-cognitive variables in the prediction of daily life functioning
was evaluated with LMM analyses. Higher age was shown to be associated with lower SF-36 PF and lower DECO
scores. Being female was associated with higher DECO scores. Depressive symptoms affected all daily life measures
negatively and higher levels of anxiety were associated with higher CFQ scores. Independently from these non-cognitive
variables, the SF-36 PF, CFQ and DECO scores were affected by the SCWT Errors, the SCWT Time, and the VLT
Delayed recall scores, respectively. The ESQ measure was associated with the SF-36 PF and CFQ scores, and the MQ
score predicted the DECO score. The GCQ measure was the only neuropsychological measure that was consistently
associated with all daily life measures (after the relevant non-cognitive variables were taken into account). The LDST
and CST scores were not related to any of the daily life measures in the final individual neuropsychological test score
models (see Table 4). It must be stressed out that this finding does not imply that the LDST and CST scores were
unrelated to daily life functioning (see also Table 3). Rather, this finding suggests that the LDST and CST scores did
not increase the amount of explained variance in the daily life measures given the non-cognitive variables, the SCWT
Time, the SCWT Errors, and/or the VLT delayed recall scores. Or, in applied terms, the CST and LDST test scores do
not improve the prediction of daily life functioning when the non-cognitive variables and the SCWT and the VLT test
scores are already considered by the neuropsychologist.
The final individual neuropsychological test score models, the final ESQ & MQ models, and the final GCQ models
explained about the same amounts of variance in daily life functioning (i.e. 4.6–21.4%, see Table 7). This finding
suggests that the seven individual neuropsychological test scores can be compressed in one or two neuropsychological
composites (i.e. the GCQ measure, and the ESQ and MQ measures) without lowering the ecological validity. As
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the GCQ measure was the most consistently related to the various daily life measures, it can be considered to be
the measure of first choice when an ecologically valid neuropsychological measure is needed. Note that models that
only included the neuropsychological measures accounted for less than 7% of the variance in daily life functioning
(models available by contacting the corresponding author). This finding clearly shows that the ecological validity of
the neuropsychological assessment can be substantially improved when non-cognitive variables are taken into account
together with the neuropsychological measures.
A number of limitations in the present study suggest possibilities for future research. First, a critical element
in ecological validity research is how everyday functioning is defined. Everyday functioning is a broad construct
that can be defined as ADL functioning, IADL functioning, functioning at work, or social functioning. Several of the
neuropsychological measures that were considered in the present study were significantly related to the ADL and IADL
measures, but it remains to be determined to what extent that these neuropsychological measures have predictive power
with respect to the other aspects of daily life functioning (e.g. functioning at work or social functioning). Moreover,
the different aspects of everyday functioning can be measured in different ways. We used self-report and informant
questionnaires to assess ADL and IADL functioning, but both methods are ‘subjective’ and indirect. Other researchers
have used laboratory-based simulations of everyday tasks (e.g. shopping and financial management) to obtain more
objective and direct measures of daily living (Farias et al., 2003; Heaton et al., 2004). It may be valuable to include both
behavior-based and questionnaire-based measures of daily living in future studies, as this could provide converging
evidence regarding the ecological validity of neuropsychological measures (especially because neuropsychological
measures seem to be more strongly related to behavior-based measures of everyday functioning than to questionnaire-
based measures; Farias et al., 2003; Heaton et al., 2004). Note, however, that certain domains of daily living may be
difficult to simulate in laboratory settings (e.g. daily life social functioning; Chaytor et al., 2007), and that practical
complications may hamper the use of behavior-based measurements of daily life functioning in large-scale studies
(e.g. considerations of time and cost-efficiency).
Second, all participants were cognitively healthy at baseline, but a proportion of the sample developed dementia
during the follow-up measurements. In our sample, n= 33 people (3.8% of the total baseline sample) were diagnosed
with dementia at the first (n= 8), second (n= 14), and third (n= 11) follow-up moments. As expected, the baseline
GCQ, ESQ and MQ scores of the participants who developed dementia during follow-up was substantially lower as
compared to the baseline scores of people who did not develop dementia during follow-up (i.e. 85.8 vs. 100.6 for the
GCQ, 92.5 vs. 100.3 for the ESQ, and 86.7 vs. 100.6 for the MQ). The data of people who developed dementia during
follow-up were not excluded from the analyses because the aim of the present study was to evaluate the ecological
validity of neuropsychological measures that were administered at the moment that a person was neurologically intact.
The question nevertheless rises whether exclusion of the data of people who developed dementia during the follow-up
measurements would have affected the results. Additional LMM analyses showed that this was not the case (data not
shown).
Third, we evaluated the ecological validity of ‘traditional’ neuropsychological tests (i.e. tests that were originally
developed to detect brain damage). An alternative approach to address the problem of ecological validity consists of
abandoning the existing traditional neuropsychological tests and creating new ones with optimal ecological validity
held explicitly in mind during the development of the instrument (i.e. the verisimilitude approach; Wilson, Alderman,
Burgess, Emslie, & Evans, 1996). Studies with neurologically impaired people have suggested that tests with verisimil-
itude may have higher ecological validity as compared to traditional neuropsychological tests, though Chaytor and
Schmitter-Edgecombe (2003) noted in their review that the evidence is limited and far from universal. It therefore
remains important to evaluate the ecological validity of traditional neuropsychological tests, also because the majority
of clinical neuropsychologists continue to use traditional tests to ground their judgments about the everyday functioning
of an individual rather than the newly developed ecologically oriented instruments (Rabin et al., 2007). Nevertheless,
future studies should also evaluate the ecological validity of verisimilitude tests in neurologically intact populations.
Fourth, it has been suggested that participants in longitudinal studies (especially older participants) may not be
representative of their peers who do not participate in longitudinal studies due to a bias towards greater health.
Compliance to participate in the MAAS was also found to be affected by health status in the group of people aged above
70 years (see Jolles, Houx, Van Boxtel, & Ponds, 1995). This bias toward greater health may affect the generalizability
of the results of the present study, but this problem exists for all longitudinal studies.
In summary, the results of the present study suggested that neuropsychological measures, demographic variables,
depressive symptoms and anxiety were associated with present and future daily life functioning (3, 6, and/or 9 years
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following the neuropsychological testing) in neurologically intact people. Between 4.6% and 21.4% of the variance
in daily life measures was accounted for by the neuropsychological measures and the non-cognitive variables. Future
studies should evaluate how the ecological validity of the neuropsychological assessment can be increased (e.g. by
including additional neuropsychological measures that assess other cognitive domains such as conceptual reasoning,
visuospatial perception, and language). The GCQ measure was the neuropsychological measure that was the most
consistently related to the various daily life measures.
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